Immunai Email Format
Biotechnology ResearchNew York, United States51-200 Employees
Immunai is a biotechnology research company based in New York City, located at 180 Varick Street, focused on mapping and decoding the human immune system. The organization employs 51-200 people. It applies single-cell biology and artificial intelligence to support the discovery of immune-modulating therapeutics and to accelerate drug development and patient outcomes. It maintains a proprietary knowledgebase named AMICA and has developed an AI model of the immune system called the IDE engine. The company has engaged in collaborations with major pharmaceutical and research institutions, including Bristol Myers Squibb and Teva, and has launched initiatives such as the Immunai Grand Collaboration Initiative for Single-Cell Immune Profiling.